MTB Drug Resistant Detection

The current methods for detecting TB drug resistance are inefficient and imprecise, leading to covering drugs that either cause or exacerbate drug resistance. Chromosomal genetic variation is the primary mechanism through which TB develops resistance to treatment.

A quick diagnosis of multidrug-resistant tuberculosis is now possible due to advances in gene chip detection technology, which can evaluate a patient’s resistance to rifampicin and isoniazid, two of the most important first-line anti-tuberculosis medications.

Features of MTB Detection

Get through all of the tests in 6 hours


Mycobacterium TB rifampicin and isoniazid resistance detection in a single sample


A total of 1186 cases were confirmed through clinical trials, and all of them matched up with the sequencing data

Targets Rifampicin resistance gene Isoniazid resistance gene
Drug resistance gene rpoB gene katG gene inhA gene
loci 511/513/516/526/531/ 315 -15
533

Specification of MTB Drug Resistant Detection
Order information
Cat. No. Description Specification
301035 CapitalBio庐M.Tuberculosis Drug Resistance Detection Array Kit 12 tests/kit

If you want to know more about mtb dna detected process, please visit our website.

With 20+ years’ experience, national scientific research platforms and bioinformatics expertise, Capitalbio Technology always dedicated to assisting researchers advance the life sciences. We have professional scientists to provide services for the whole process, from free consulting and experiment design to data interpretation.

Now the price of in vitro diagnostics kits if reasonable, if you have needs, please contact us.